REVANCE THERAPEUTICS INC (RVNC) Stock Analyst Ratings
NASDAQ:RVNC - Nasdaq - US7613301099 - Common Stock
ChartMill assigns a Buy % Consensus number of 71% to RVNC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.71. This target is 110.91% above the current price.
RVNC was analyzed by 15 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about RVNC.
In the previous month the buy percentage consensus was at a similar level.
RVNC was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-17 | Needham | Reiterate | Hold -> Hold |
| 2024-12-23 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-10 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-11-08 | Needham | Reiterate | Hold |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-10-28 | Needham | Reiterate | Hold |
| 2024-09-13 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-08-13 | Needham | Downgrade | Buy -> Hold |
| 2024-08-12 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-08-12 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-08-09 | Needham | Reiterate | Buy -> Buy |
| 2024-08-09 | Stifel | Maintains | Buy -> Buy |
| 2024-08-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-05-13 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-10 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-05-10 | Needham | Maintains | Buy -> Buy |
| 2024-05-10 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-01 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-02-29 | Needham | Maintains | Buy -> Buy |
| 2024-02-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-29 | Mizuho | Downgrade | Buy -> Neutral |
| 2024-01-29 | Barclays | Maintains | Overweight -> Overweight |
| 2024-01-09 | Needham | Maintains | Buy -> Buy |
| 2024-01-09 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-11-22 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-09 | Needham | Maintains | Buy -> Buy |
| 2023-11-09 | Piper Sandler | Maintains | Overweight -> Overweight |